Raymond James & Associates’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.2M | Sell |
14,250
-7,025
| -33% | -$1.58M | ﹤0.01% | 1930 |
|
|
2024
Q2 | $3.04M | Buy |
21,275
+76
| +0.4% | +$10.8K | ﹤0.01% | 1911 |
|
|
2024
Q1 | $3.32M | Buy |
21,199
+8,602
| +68% | +$1.35M | ﹤0.01% | 1844 |
|
|
2023
Q4 | $2.27M | Sell |
12,597
-478
| -4% | -$86.2K | ﹤0.01% | 2019 |
|
|
2023
Q3 | $2.35M | Sell |
13,075
-2,821
| -18% | -$507K | ﹤0.01% | 1913 |
|
|
2023
Q2 | $2.83M | Sell |
15,896
-1,277
| -7% | -$228K | ﹤0.01% | 1841 |
|
|
2023
Q1 | $3.7M | Buy |
17,173
+2,402
| +16% | +$518K | ﹤0.01% | 1665 |
|
|
2022
Q4 | $3.25M | Buy |
14,771
+176
| +1% | +$38.7K | ﹤0.01% | 1700 |
|
|
2022
Q3 | $1.97M | Sell |
14,595
-425
| -3% | -$57.3K | ﹤0.01% | 1962 |
|
|
2022
Q2 | $2.43M | Sell |
15,020
-253
| -2% | -$40.9K | ﹤0.01% | 1870 |
|
|
2022
Q1 | $2.88M | Buy |
15,273
+3,047
| +25% | +$575K | ﹤0.01% | 1877 |
|
|
2021
Q4 | $3.31M | Buy |
12,226
+304
| +3% | +$82.4K | ﹤0.01% | 1820 |
|
|
2021
Q3 | $4.33M | Buy |
11,922
+1,259
| +12% | +$457K | ﹤0.01% | 1592 |
|
|
2021
Q2 | $3.66M | Buy |
10,663
+6,046
| +131% | +$2.07M | ﹤0.01% | 1708 |
|
|
2021
Q1 | $1.61M | Buy |
4,617
+1,067
| +30% | +$371K | ﹤0.01% | 2166 |
|
|
2020
Q4 | $917K | Sell |
3,550
-2,198
| -38% | -$568K | ﹤0.01% | 2399 |
|
|
2020
Q3 | $1.65M | Buy |
5,748
+3,546
| +161% | +$1.02M | ﹤0.01% | 1876 |
|
|
2020
Q2 | $415K | Buy |
+2,202
| New | +$415K | ﹤0.01% | 2705 |
|
|
2020
Q1 | – | Sell |
-1,692
| Closed | -$280K | – | 3620 |
|
|
2019
Q4 | $280K | Buy |
+1,692
| New | +$280K | ﹤0.01% | 3105 |
|
|
2019
Q1 | – | Sell |
-3,050
| Closed | -$428K | – | 3570 |
|
|
2018
Q4 | $428K | Buy |
3,050
+476
| +18% | +$66.8K | ﹤0.01% | 2638 |
|
|
2018
Q3 | $443K | Buy |
+2,574
| New | +$443K | ﹤0.01% | 2783 |
|
|
2018
Q2 | – | Sell |
-1,529
| Closed | -$257K | – | 3541 |
|
|
2018
Q1 | $257K | Buy |
+1,529
| New | +$257K | ﹤0.01% | 2974 |
|